The mucosal immune system: from fundamental concepts to vaccine development
- PMID: 1539467
- DOI: 10.1016/0264-410x(92)90021-b
The mucosal immune system: from fundamental concepts to vaccine development
Abstract
Recent studies in experimental animals and humans have shown that the mucosal immune system, which is characterized by secretory IgA (S-IgA) antibodies as the major humoral defence factor, contains specialized lymphoid tissues where antigens are encountered from the environment, are taken up and induce B- and T-cell responses. This event is followed by an exodus of specific lymphocytes, which home to various effector sites such as the lamina propria regions and glands. These responses are regulated by T cells and cytokines and lead to plasma cell differentiation and subsequent production of S-IgA antibodies in external secretions. This knowledge has led to practical approaches for vaccine construction and delivery into mucosal inductive sites in an effort to elicit host protection at mucosal surfaces where the infection actually occurs.
Similar articles
-
In defense of mucosal surfaces. Development of novel vaccines for IgA responses protective at the portals of entry of microbial pathogens.Infect Dis Clin North Am. 1990 Jun;4(2):315-41. Infect Dis Clin North Am. 1990. PMID: 2189002 Review.
-
New perspectives in vaccine development: mucosal immunity to infections.Infect Agents Dis. 1993 Apr;2(2):55-73. Infect Agents Dis. 1993. PMID: 8162356 Review.
-
Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems.J Immunol. 2017 Jul 1;199(1):9-16. doi: 10.4049/jimmunol.1601775. J Immunol. 2017. PMID: 28630108 Free PMC article. Review.
-
Mucosal immunity: induction, dissemination, and effector functions.Scand J Immunol. 2009 Dec;70(6):505-15. doi: 10.1111/j.1365-3083.2009.02319.x. Scand J Immunol. 2009. PMID: 19906191 Review.
-
New perspectives in mucosal immunity with emphasis on vaccine development.Semin Hematol. 1993 Oct;30(4 Suppl 4):3-12; discussion 13-5. Semin Hematol. 1993. PMID: 8303308 Review.
Cited by
-
Design and application of chitosan microspheres as oral and nasal vaccine carriers: an updated review.Int J Nanomedicine. 2012;7:6077-93. doi: 10.2147/IJN.S38330. Epub 2012 Dec 13. Int J Nanomedicine. 2012. PMID: 23271909 Free PMC article. Review.
-
Effects of the Probiotic Mixture Slab51® (SivoMixx®) as Food Supplement in Healthy Dogs: Evaluation of Fecal Microbiota, Clinical Parameters and Immune Function.Front Vet Sci. 2020 Sep 4;7:613. doi: 10.3389/fvets.2020.00613. eCollection 2020. Front Vet Sci. 2020. PMID: 33102555 Free PMC article.
-
Protective immunity and antibody-secreting cell responses elicited by combined oral attenuated Wa human rotavirus and intranasal Wa 2/6-VLPs with mutant Escherichia coli heat-labile toxin in gnotobiotic pigs.J Virol. 2001 Oct;75(19):9229-38. doi: 10.1128/JVI.75.19.9229-9238.2001. J Virol. 2001. PMID: 11533185 Free PMC article.
-
Nasal immunization with homogenate and peptide antigens induces protective immunity against Trichinella spiralis.Infect Immun. 2002 Dec;70(12):7149-52. doi: 10.1128/IAI.70.12.7149-7152.2002. Infect Immun. 2002. PMID: 12438399 Free PMC article.
-
The immune responses to bacterial antigens encountered in vivo at mucosal surfaces.Philos Trans R Soc Lond B Biol Sci. 2000 May 29;355(1397):705-12. doi: 10.1098/rstb.2000.0610. Philos Trans R Soc Lond B Biol Sci. 2000. PMID: 10874742 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous